Limbic AI
Limbic AI, legally identified in public profiles as Limbic Limited, is a private UK healthcare technology company developing clinical artificial intelligence for mental healthcare. Its products support patient intake and self-referral, clinical assessment, triage, diagnostic decision support, caseload management, and therapy support, including AI-assisted cognitive behavioral therapy. The company reports deployments across NHS mental-health services and expansion into U.S. healthcare providers. Its flagship Limbic Access product has UK Class IIa medical-device certification, and the company states that it operates under ISO 13485 quality-management processes and maintains HIPAA, GDPR, and ISO 27001 compliance. Publicly reported market indicators include more than 650,000 assessed patients and use by approximately 45% of NHS Talking Therapies services; these figures are company-reported and may change over time.
Company Details
- Website
- limbic.ai
- Headquarters
- London, England, United Kingdom
- Founded
- 2017
- Funding
- $19.4M publicly reported, comprising a reported $5.4M September 2021 seed round and $14M Series A an
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring